Sinoway Industrial Co., Ltd.

Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6 Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6
Related Products
  • Mupirocin 12650-69-0

    Details of MupirocinOther Names: mupirocinMF: C26H44O9Place of Origin: Fujian, China (Mainland)Type: Auxiliaries and Other Medicinal Chemicals, Immune Function AgentsGrade Standard: Medicine GradeBran...

  • Atracurium Besylate 64228-81-5

    Basic information of Atracurium besylate:NameAtracurium besylateAliasCAS NO.64228-81-5 Molecular FormulaC65H82N2O18S2Molecular Weight1243.48Quality StandardCurrent USPPackage Size2kg or 3kg/tin/carton...

  • Ceftiofur Sodium 104010-37-9

    Basic information of Ceftiofur sodium:NameCeftiofur sodiumCAS :104010-37-9Molecular FormulaC19H16N5NaO7S3Molecular Weight545.54Quality StandardPackage SizeFor small quantity:Double plastic bag inside ...

Basic Information of Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

  • CAS No of key intermediate.: 675198-19-3
  • 117977-21-6
  • EINECS No.: 117976-90-6
  • Purity: 99.0%
  • Application: Pharmaceutical intermediates
  • Appearance: White Powder, White Powder
  • Molecular Weight: 381.42400
  • Molecular formula: C18H20N3NaO3S

Usage of Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

  • Rabeprazole sodium, indications for the product is suitable for the following treatment: 1. Active duodenal ulcer; 2. Benign active gastric ulcer; 3. With clinical symptoms of aggressive or ulcerative gastric - esophageal reflux syndrome (GORD); 4 with appropriate antibiotics, can cure Helicobacter pylori-positive duodenal ulcer; 5 erosion or ulcerative gastric - esophageal reflux sign of maintenance treatment.

Note:

  1. The symptoms of treatment with sodium rabeprazole do not rule out the presence of stomach or esophageal cancer. Therefore, before using this product to start treatment should rule out the possibility of cancer. Although there are no obvious drug-related safety issues in age-sex matched controls with mild-to-moderate liver injury, the physician recommends special care when first treated with this product.
  2. Taking this product should be regularly carried out blood tests and blood biochemistry (such as liver enzyme test), found abnormal, that is, stop the medication, and timely treatment.
  3. Caution in patients with liver damage.

MORE_DETAIL Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

Basic Information of Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

  • CAS No of key intermediate.: 675198-19-3
  • 117977-21-6
  • EINECS No.: 117976-90-6
  • Purity: 99.0%
  • Application: Pharmaceutical intermediates
  • Appearance: White Powder, White Powder
  • Molecular Weight: 381.42400
  • Molecular formula: C18H20N3NaO3S

Usage of Rabeprazole Sodium Intermediates 675198-19-3/117977-21-6

  • Rabeprazole sodium, indications for the product is suitable for the following treatment: 1. Active duodenal ulcer; 2. Benign active gastric ulcer; 3. With clinical symptoms of aggressive or ulcerative gastric - esophageal reflux syndrome (GORD); 4 with appropriate antibiotics, can cure Helicobacter pylori-positive duodenal ulcer; 5 erosion or ulcerative gastric - esophageal reflux sign of maintenance treatment.

Note:

  1. The symptoms of treatment with sodium rabeprazole do not rule out the presence of stomach or esophageal cancer. Therefore, before using this product to start treatment should rule out the possibility of cancer. Although there are no obvious drug-related safety issues in age-sex matched controls with mild-to-moderate liver injury, the physician recommends special care when first treated with this product.
  2. Taking this product should be regularly carried out blood tests and blood biochemistry (such as liver enzyme test), found abnormal, that is, stop the medication, and timely treatment.
  3. Caution in patients with liver damage.
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//